Article

A Controlling Nature Can Take a Toll on a Caregiver

Author(s):

Overattentive caregivers can undermine patient recovery.

Overbearing caregivers can have an adverse effect on their patients—but their controlling nature can also compromise their own health, experts warn.

"There is a very high level of self-imposed stress that comes with the need to control a situation,” notes Iris Cohen Fineberg, president of the Association of Oncology Social Work. Controlling caregivers “need to know every piece of information and be involved in every decision— and that level of stress for an ongoing period is wearing. It can lead to more rapid caregiver burnout, including depression and anxiety, because the caregiver is pushing so hard all the time.”

Indeed, such efforts can easily compromise a caregiver’s physical and mental well-being, adds Rachel Cannady, a behavioral scientist with the American Cancer Society. “There is a direct link between being overly controlling and health issues among caregivers,” she observes. “We have seen in our studies where caregivers report lower quality-of-life scores than the patients they are caring for, and that’s often because of the multiple demands they are juggling.” In some cases, Cannady says, the caregiving dynamic may become so toxic that it ruins familial relationships and dissolves marriages.

Another problem associated with an overbearing personality is a complicated bereavement if the patient dies, says Timothy J. Moynihan, an oncologist at the Mayo Clinic in Rochester, Minn. When the caregiver loses the primary focus of his or her life, Moynihan explains, bereavement goes on much longer than normal because the caregiver lacks the coping skills to deal effectively with the patient’s death.

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Related Content